» Articles » PMID: 2931222

In Vitro Studies on the Mechanism of Increased Serum IgM Levels in Primary Biliary Cirrhosis

Overview
Date 1985 Aug 1
PMID 2931222
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

To evaluate the mechanisms underlying the increase in serum IgM in primary biliary cirrhosis (PBC) studies were designed to examine IgM production in vitro and to assess the relative contribution of intrinsic B cell activity and immunoregulatory T cell balance to IgM synthesis. The number of peripheral blood lymphocytes (PBL) producing IgM (spontaneous and pokeweed mitogen (PWM) stimulated) at the end of a seven day culture period was similar in PBC patients and control subjects while the amount of IgM synthesized (spontaneous and PWM stimulated) during this period was significantly greater in the patient group, implying that the amount of IgM produced per B cell was increased in PBC. Co-culture of autologous and allogeneic T and B lymphocytes and irradiation of T lymphocytes from patients and normal subjects clearly implicated abnormal suppressor T cell function, rather than autonomous B cell hyperactivity, as the cause of the increased IgM synthesis. Direct studies of T cell function indicated that although concanavalin A (Con A) activated suppressor cells inhibited proliferation of IgM producing B cells in the majority of PBC patients, they were unable to inhibit IgM synthesis. The demonstration of a disparity between IgM synthesis and the proliferation of IgM-producing B cells, together with the observation that the abnormality of T cell function is largely confined to the control of IgM secretion, is consistent with the presence of at least two different suppressor subpopulations regulating IgM production. In PBC the main suppressor cell abnormality seems to affect regulation of IgM secretion rather than B cell proliferation.

Citing Articles

The coexistence of Sjögren's syndrome and primary biliary cirrhosis: a comprehensive review.

Sun Y, Zhang W, Li B, Zou Z, Selmi C, Gershwin M Clin Rev Allergy Immunol. 2015; 48(2-3):301-15.

PMID: 25682089 DOI: 10.1007/s12016-015-8471-1.


Antibody responses to tetanus toxoid in patients with primary biliary cirrhosis.

Watmough D, French M, Triger D J Clin Pathol. 1987; 40(6):683-6.

PMID: 3497181 PMC: 1141063. DOI: 10.1136/jcp.40.6.683.


Lymphocytes from patients with primary biliary cirrhosis spontaneously secrete high levels of IgG3 in culture.

Bird P, Calvert J, Mitchison H, LING N, Bassendine M, James O Clin Exp Immunol. 1988; 71(3):475-80.

PMID: 3133143 PMC: 1541685.


Primary biliary cirrhosis: new perspectives.

Maddrey W Trans Am Clin Climatol Assoc. 1988; 100:142-54.

PMID: 3077573 PMC: 2376463.


Anti-mitochondrial antibody IgG subclass distribution and affinity in primary biliary cirrhosis.

Zhang L, Weetman A, Jayne D, Turner I, Yeaman S, Bassendine M Clin Exp Immunol. 1992; 88(1):56-61.

PMID: 1563107 PMC: 1554353. DOI: 10.1111/j.1365-2249.1992.tb03039.x.

References
1.
Doniach D, Roitt I, Walker J, Sherlock S . Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications. Clin Exp Immunol. 1966; 1(3):237-62. PMC: 1579190. View

2.
Allison A, DENMAN A, Barnes R . Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet. 1971; 2(7716):135-40. DOI: 10.1016/s0140-6736(71)92306-3. View

3.
Sherlock S, Scheuer P . The presentation and diagnosis of 100 patients with primary biliary cirrhosis. N Engl J Med. 1973; 289(13):674-8. DOI: 10.1056/NEJM197309272891306. View

4.
Shou L, Schwartz S, GOOD R . Suppressor cell activity after concanavalin A treatment of lymphocytes from normal donors. J Exp Med. 1976; 143(5):1100-10. PMC: 2190183. DOI: 10.1084/jem.143.5.1100. View

5.
Thomas H, Holden R, Jones J, PEACOCK D . Immune response to phi X 174 in man. 5. Primary and secondary antibody production in primary biliary cirrhosis. Gut. 1976; 17(11):844-8. PMC: 1411209. DOI: 10.1136/gut.17.11.844. View